Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth.
Spinal Tech
Max Reinhardt has been elected to the board of directors at Sure Retractors, a medical device company specializing in spinal surgery solutions.
ZimVie on Aug. 10 reported net sales of $233.4 million in the second quarter.
AxioMed's artificial disc nears FDA approval and five more key updates from spine devicemakers since Aug. 3:
From robotic joint replacements to predicting pain outcomes, artificial intelligence is being used in a variety of ways in orthopedics.
Surgalign's artificial intelligence and augmented reality surgical guidance system, Holo Portal, debuted in the second quarter, and the devicemaker plans to grow its footprint by 2023.
Spine devicemaker Surgalign reported year-over-year revenue decreases in the second quarter and the first half of 2022, according to results posted Aug. 9.
NuVasive's executive vice president and chief commercial officer, Massimo Calafiore, is stepping down, the devicemaker said Aug. 9.
AxioMed completed the final steps toward FDA approval for its lumbar viscoelastic disc replacement device.
Alphatec posted significant year-over-year second-quarter growth and an increase in its surgeon user base, according to results posted Aug. 4.
